Charles Schwab Investment Management Inc Halozyme Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,342,831 shares of HALO stock, worth $87.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,342,831
Previous 1,748,851 23.22%
Holding current value
$87.5 Million
Previous $112 Million 37.4%
% of portfolio
0.01%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$47.91 - $70.14 $19.5 Million - $28.5 Million
-406,020 Reduced 23.22%
1,342,831 $69.9 Million
Q1 2025

Sep 15, 2025
BUY
$47.74 - $65.16 $19.4 Million - $26.5 Million
406,020 Added 30.24%
1,748,851 $112 Million
Q1 2025

May 09, 2025
SELL
$47.74 - $65.16 $1.64 Million - $2.24 Million
-34,326 Reduced 1.92%
1,748,851 $112 Million
Q4 2024

Feb 06, 2025
BUY
$42.57 - $61.09 $416,334 - $597,460
9,780 Added 0.55%
1,783,177 $85.3 Million
Q3 2024

Nov 12, 2024
SELL
$51.3 - $64.42 $725,946 - $911,607
-14,151 Reduced 0.79%
1,773,397 $101 Million
Q2 2024

Aug 12, 2024
BUY
$37.81 - $52.4 $4.54 Million - $6.29 Million
120,069 Added 7.2%
1,787,548 $93.6 Million
Q1 2024

May 08, 2024
SELL
$33.68 - $41.95 $2.31 Million - $2.88 Million
-68,643 Reduced 3.95%
1,667,479 $67.8 Million
Q4 2023

Feb 06, 2024
BUY
$33.32 - $42.1 $1.26 Million - $1.59 Million
37,763 Added 2.22%
1,736,122 $64.2 Million
Q3 2023

Nov 08, 2023
BUY
$36.46 - $44.03 $579,786 - $700,165
15,902 Added 0.95%
1,698,359 $64.9 Million
Q2 2023

Aug 09, 2023
SELL
$30.28 - $38.74 $106,525 - $136,287
-3,518 Reduced 0.21%
1,682,457 $60.7 Million
Q1 2023

May 11, 2023
BUY
$32.86 - $55.7 $2.4 Million - $4.06 Million
72,969 Added 4.52%
1,685,975 $64.4 Million
Q4 2022

Feb 13, 2023
BUY
$40.06 - $59.44 $97,225 - $144,260
2,427 Added 0.15%
1,613,006 $91.8 Million
Q3 2022

Nov 14, 2022
BUY
$38.53 - $51.78 $13.6 Million - $18.3 Million
352,662 Added 28.04%
1,610,579 $63.7 Million
Q2 2022

Aug 15, 2022
SELL
$37.35 - $48.3 $2.51 Million - $3.25 Million
-67,280 Reduced 5.08%
1,257,917 $55.3 Million
Q1 2022

May 13, 2022
BUY
$31.97 - $41.06 $977,706 - $1.26 Million
30,582 Added 2.36%
1,325,197 $52.8 Million
Q4 2021

Feb 11, 2022
SELL
$31.82 - $40.75 $631,658 - $808,928
-19,851 Reduced 1.51%
1,294,615 $52.1 Million
Q3 2021

Nov 16, 2021
BUY
$38.47 - $46.42 $3.28 Million - $3.96 Million
85,223 Added 6.93%
1,314,466 $53.5 Million
Q2 2021

Aug 16, 2021
BUY
$38.84 - $51.31 $3.3 Million - $4.36 Million
84,974 Added 7.43%
1,229,243 $55.8 Million
Q1 2021

May 17, 2021
BUY
$39.51 - $51.45 $7.83 Million - $10.2 Million
198,156 Added 20.94%
1,144,269 $47.7 Million
Q4 2020

Feb 16, 2021
SELL
$25.81 - $43.62 $5,265 - $8,898
-204 Reduced 0.02%
946,113 $40.4 Million
Q3 2020

Nov 13, 2020
BUY
$25.74 - $29.63 $1.32 Million - $1.52 Million
51,156 Added 5.71%
946,317 $24.9 Million
Q2 2020

Aug 14, 2020
BUY
$16.25 - $26.81 $756,388 - $1.25 Million
46,547 Added 5.49%
895,161 $24 Million
Q1 2020

May 15, 2020
SELL
$13.9 - $21.83 $524,697 - $824,038
-37,748 Reduced 4.26%
848,614 $15.3 Million
Q4 2019

Feb 07, 2020
SELL
$14.93 - $19.53 $277,459 - $362,945
-18,584 Reduced 2.05%
886,362 $15.7 Million
Q3 2019

Nov 08, 2019
BUY
$15.2 - $17.69 $297,813 - $346,600
19,593 Added 2.21%
904,946 $14 Million
Q2 2019

Aug 09, 2019
BUY
$14.75 - $17.26 $650,062 - $760,682
44,072 Added 5.24%
885,353 $15.2 Million
Q1 2019

May 14, 2019
BUY
$13.94 - $17.58 $2.04 Million - $2.57 Million
146,198 Added 21.03%
841,281 $13.5 Million
Q4 2018

Feb 14, 2019
SELL
$13.33 - $18.66 $3.27 Million - $4.58 Million
-245,209 Reduced 26.08%
695,083 $10.2 Million
Q3 2018

Nov 13, 2018
SELL
$16.68 - $18.41 $983,586 - $1.09 Million
-58,968 Reduced 5.9%
940,292 $17.1 Million
Q2 2018

Aug 08, 2018
BUY
$16.87 - $20.3 $1.22 Million - $1.47 Million
72,392 Added 7.81%
999,260 $16.9 Million
Q1 2018

May 07, 2018
BUY
$17.06 - $21.2 $4.54 Million - $5.64 Million
265,855 Added 40.22%
926,868 $18.2 Million
Q4 2017

Jan 17, 2018
BUY
$16.75 - $20.8 $1.52 Million - $1.88 Million
90,500 Added 15.86%
661,013 $13.4 Million
Q3 2017

Nov 13, 2017
BUY
$11.76 - $17.4 $6.71 Million - $9.93 Million
570,513
570,513 $9.91 Million

Others Institutions Holding HALO

# of Institutions
631
Shares Held
127M
Call Options Held
408K
Put Options Held
384K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $9.08B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email